{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HRTS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HRTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRTS\",,,,,undefined,":{"symbol":"HRTS","market":"US","secType":"STK","nameCN":"Tema GLP-1, Obesity & Cardiometabolic ETF","latestPrice":27.98,"timestamp":1750449600000,"preClose":28.27,"halted":0,"volume":3247,"hourTrading":{"tag":"盘后","latestPrice":28.08,"preClose":27.98,"latestTime":"16:04 EDT","volume":2,"amount":55.96,"timestamp":1750449849065},"delay":0,"floatShares":1780000,"shares":1780000,"eps":0,"marketStatus":"Market Closed","change":-0.29,"latestTime":"06-20 16:00:00 EDT","open":28.37,"high":28.37,"low":27.98,"amount":91208.5099,"amplitude":0.013796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":28.27,"sharesOutstanding":1780000,"nav":28.23,"aum":50249400,"dividendRate":0.016798,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.08,"preClose":27.98,"latestTime":"16:04 EDT","volume":2,"amount":55.96,"timestamp":1750449849065},"volumeRatio":0.9036513741162969,"impliedVol":0.1001,"impliedVolPercentile":0.28},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRTS\",,,,,undefined,":{"symbol":"HRTS","floatShares":1780000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9036513741162969,"shares":1780000,"dividePrice":0.47,"high":28.37,"amplitude":0.013796,"preClose":28.27,"low":27.98,"week52Low":25.3192,"pbRate":"--","week52High":36.03,"institutionHeld":0,"latestPrice":27.98,"eps":0,"divideRate":0.016798,"volume":3247,"delay":0,"ttmEps":0,"open":28.37,"prevYearClose":28.87,"prevWeekClose":28.81,"prevMonthClose":27.78,"prevQuarterClose":29.33,"fiveDayClose":29.19,"twentyDayClose":27.46,"sixtyDayClose":29.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HRTS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2476921108","title":"Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2476921108","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476921108?lang=en_us&edition=fundamental","pubTime":"2024-10-17 01:47","pubTimestamp":1729100820,"startTime":"0","endTime":"0","summary":"In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global obesity rate has nearly tripled since 1975 and is expected to affect over half the population by 2035,per WHO and Goldman Sachs. The global market for anti-obesity medications is expected to reach $50 billion by 2030.As the prevalence of obesity rises, so do related chronic conditions such as diabetes, heart disease and hypertension, creating a massive market for treatments like GLP-1 drugs. Pioneering GLP-1 treatments, such as Ozempic, Wegovy and Zepbound, are now at the forefront of medical advancements in weight management.Two companies — Eli Lilly LLY and Novo Nordisk NVO — dominate the weight-loss drug market and their stocks have surged in the recent past due to soaring demand for their products. There are a few other ways to play this market. Exchange-traded funds  are the best way","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vEcnkVRWY1.AKxOmZ2RQiQ--~B/aD00MTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9080893d83d7b91adebaa73de0275743","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vEcnkVRWY1.AKxOmZ2RQiQ--~B/aD00MTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9080893d83d7b91adebaa73de0275743"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inside-booming-obesity-drug-market-174700789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","PPH","FDN","LU0943347566.SGD","LU1061106388.HKD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0097036916.USD","LU0689472784.USD","BK4516","LU0882574139.USD","NVO","BK4534","GB00BDT5M118.USD","LU0256863811.USD","LU1093756325.SGD","LU0109391861.USD","IE00BKVL7J92.USD","IE00BJLML261.HKD","LU0061475181.USD","LU0114720955.EUR","BK4550","LU0289739699.SGD","LU1023059063.AUD","LU1093756168.USD","IE00BJT1NW94.SGD","HRTS","THNR","IE0009355771.USD","BK4585","BK4533","LU0820561909.HKD","LU0094547139.USD","LU0354030438.USD","IE0004445239.USD","LU0471298694.HKD","LU0882574055.USD","LU0354030511.USD","LU1035775433.USD","LU0385154629.USD","LLY","LU1069344957.HKD","LU0708995401.HKD","LU0006306889.USD","BK4007","LU0096364046.USD","IE0002141913.USD","LU1057294990.SGD","LU0122379950.USD","LU0079474960.USD"],"gpt_icon":1},{"id":"2468531787","title":"Tap the Weight-Loss Drug Market With These ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=2468531787","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468531787?lang=en_us&edition=fundamental","pubTime":"2024-09-18 23:00","pubTimestamp":1726671600,"startTime":"0","endTime":"0","summary":"The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are also vying for a slice of the lucrative business. The latest data from Roche Holdings RHHBY, Novo Nordisk and smaller biotech proved that an oral option could be as effective as injectables.The new drugs in the pipeline are getting approval with potential for improvements such as less frequent administration by pill rather than by injection and fewer side effects .Investors seeking to tap the boom in weight-loss drug treatments could consider Roundhill GLP-1 & Weight Loss ETF OZEM, Amplify Weight Loss Drug & Treatment ETF THNR and GLP-1, Obesity & Cardiometabolic ETF HRTS.Roundhill GLP-1 & Weight Loss ETF Roundhill GLP-1 & Weight Loss ETF is the world’s first GLP-1 ETF and is actively managed. Roundhill believes that weight loss drugs, inclu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1H9NqoSNLfLtMd2fyMlfBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1H9NqoSNLfLtMd2fyMlfBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tap-weight-loss-drug-market-150000819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","IE0002141913.USD","LU1061106388.HKD","LLY","LU0882574139.USD","BK4516","LU1069344957.HKD","RHHBY","IE00BJJMRZ35.SGD","FDN","LU0354030511.USD","LU1035775433.USD","LU0689472784.USD","LU1093756325.SGD","03165","BK4007","IE00BKVL7J92.USD","BK4533","LU0820561818.USD","LU0122379950.USD","LU0198837287.USD","LU1064131342.USD","BK4585","IE00BJLML261.HKD","LU0471298694.HKD","NVO","LU1551013342.USD","LU0114720955.EUR","LU0466842654.USD","LU0820561909.HKD","LU0079474960.USD","BK4550","LU0097036916.USD","HRTS","LU0640476718.USD","LU0096364046.USD","THNR","LU0943347566.SGD","LU0256863811.USD","LU0354030438.USD","OZEM","GB00BDT5M118.USD","IE0004445239.USD","BK4588","LU0385154629.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1280957306.USD","IE0009355771.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HRTS\",params:#limit:5,,,undefined,":[{"date":"2024-12-11","symbol":"HRTS","amount":0.46931,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"Tema Cardiovascular and Metabolics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HRTS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.46931,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HRTS\",market:\"US\",delay:false,,,undefined,":{}}}